Postmastectomy radiotherapy of the chest wall: Comparison of electron-rotation technique and common tangential photon fields

Strahlentherapie und Onkologie

Volumn 180, Issue 10, 2004, Pages 629-636

  Hehr, Thomas ^a,b   Classen, Johannes ^a   Huth, Marco ^a   Durst, Ilona ^a   Christ, Gunter ^a   Bamberg, Michael ^a   Budach, Wilfried ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b CRONA Hoppe Seyler Str 3 72076   (Germany)

Author keywords

Electron beam rotation irradiation; Locally advanced breast cancer; Mastectomy; Prognostic and predictive factors; Radiotherapy

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ARTICLE; BREAST CANCER; CANCER RADIOTHERAPY; CANCER SURVIVAL; ELECTRON BEAM; ELECTRON BEAM ROTATION IRRADIATION; ERYTHEMA; FEMALE; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MASTECTOMY; PHOTON; POSTOPERATIVE CARE; PROGNOSIS; RADIATION DOSE FRACTIONATION; RADIATION INJURY; RADIATION PNEUMONIA; SKIN TOXICITY; TANGENTIAL PHOTON FIELD; THORAX WALL; TREATMENT OUTCOME;

ABDOMEN; ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; ELECTRONS; FEMALE; GERMANY; HUMANS; LYMPHATIC METASTASIS; MASTECTOMY; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PHOTONS; PREVALENCE; PROGNOSIS; RADIOTHERAPY; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 5444238959     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00066-004-1264-8     Document Type: Article

References (41)

1. Abdel-Wahab M, Wolfson A, Raub W. The importance of postoperative radiation therapy in multimodality treatment of locally advanced breast cancer: a phase II trial of neoadjuvant MVAC, surgery, and radiation. Int J Radiat Oncol Biol Phys 1998;40:876-80.
2. Blomqvist C,Tiusanen K, Elomaa I, et al. The combination of radiotherapy, adjuvant chemotherapy (cyclophosphamide-doxorubicin-ftorafur) and tamoxifen in stage II breast cancer. Long-term follow-up results of a randomised trial. Br J Cancer 1992;66:1171-6.
3. Chen KK, Montague ED, Oswald MJ. Results of irradiation in the treatment of locoregional breast cancer recurrence. Cancer 1985;56:1269-73.
4. Cuzick J, Stewart H, Rutquist L, et al. Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy. J Clin Oncol 1994;12:447-53.
5. Dunst J, Steil B, Furch S, et al. Prognostic significance of local recurrence in breast cancer after postmastectomy radiotherapy [Review]. Strahlenther Onkol 2001;177:504-10.
6. Emami B, Lyman J, Brown A, et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 1991;21:109-22.
7. Fletcher GH, McNeese MD, Oswald MJ. Long-range results for breast cancer patients treated by radical mastectomy and postoperative radiation without adjuvant chemotherapy: an update. Int J Radiat Oncol Biol Phys 1989;17:11-4.
8. Fodor J, Polgar C, Major T, et al. Locoregional failure 15 years after mastectomy in women with one to three positive axillary nodes with or without irradiation. The significance of tumor size. Strahlenther Onkol 2003;179:197-202.
9. Fowble B, Glick J, Goodman R. Radiotherapy for the prevention of local-regional recurrence in high risk patients post mastectomy receiving adjuvant chemotherapy. Int J Radiat Oncol Biol Phys 1988;15:627-31.
10. Fowble B, Gray R, Gilchrist K, et al. Identification of a subgroup of patients with breast cancer and histologically positive axillary nodes receiving adjuvant chemotherapy who may benefit from postoperative radiotherapy. J Clin Oncol 1988;6:1107-17.
11. Gerlach B, Audretsch W, Gogolin F, et al. Remission rates in breast cancer treated with preoperative chemotherapy and radiotherapy. Strahlenther Onkol 2003;179:306-11.
12. Griem KL, Henderson IC, Gelman R, et al. The 5-year results of a randomized trial of adjuvant radiation therapy after chemotherapy in breast cancer patients treated with mastectomy. J Clin Oncol 1987;5:1546-55.
13. Grohn P, Heinonen E, Klefstrom P, et al. Adjuvant postoperative radiotherapy, chemotherapy, and immunotherapy in stage III breast cancer. Cancer 1984;54:670-4.
14. Gruber G, Berclaz G, Altermatt HJ, et al. Can the addition of regional radiotherapy counterbalance important risk factors in breast cancer patients with extracapsular invasion of axillary lymph node metastases? Strahlenther Onkol 2003;179:661-6.
15. Hehr T, Budach W, Durst I, et al. Postmastectomy electron-beam-rotation irradiation in locally advanced breast cancer: prognostic factors of locoregional tumour control. Strahlenther Onkol 2002;178:624-32.
16. Hehr T, Budach W, Paulsen F, et al. Evaluation of predictive factors for local tumour control after electron-beam-rotation irradiation of the chest wall in locally advanced breast cancer. Radiother Oncol 1999;50:283-9.
17. Hermanek P, Hutter RVP, Sobin LH, et al., Hrsg. TNM-Atlas, 4. Aufl. Berlin-Heidelberg-New York: Springer, 1998.
18. Host H, Brennhovd IO, Loeb M. Postoperative radiotherapy in breast cancer -long-term results from the Oslo study. Int J Radiat Oncol Biol Phys 1986;12:727-32.
19. Lee ET. Statistical methods for survival data analysis. New York: Wiley, 1992.
20. Lind PA, Gagliardi G, Wennberg B, et al. A descriptive study of pulmonary complications after postoperative radiation therapy in node-positive stage II breast cancer. Acta Oncol 1997;36:509-15.
21. Marks LB, dough R, Fan M, et al. Radiation (RT)-induced pneumonitis following tangential breast/chest wall irradiation. Int J Radiat Oncol Biol Phys 2000;48:294.abstract 2060.
22. Mayer A, Naszaly A, Patyanik M, et al. Perioperative brachytherapy for prereated chest wall recurrence of breast cancer. Strahlenther Onkol 2002;178:633-6.
23. McArdle CS, Crawford D, Dykes EH, et al. Adjuvant radiotherapy and chemotherapy in breast cancer. Br J Surg 1986;73:264-6.
24. Overgaard M. Overview of randomized trials in high risk breast cancer patients treated with adjuvant systemic therapy with or without postmastectomy irradiation. Semin Radiat Oncol 1999;9:292-9.
25. Overgaard M, Hansen PS, Overgaard J, et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med 1997;337:949-55.
26. Overgaard M, Jensen MB, Overgaard J, et al. Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c Randomised Trial. Lancet 1999;353:1641-8.
27. Pierce LJ, Butler JB, Martel MK, et al. Postmastectomy radiotherapy of the chest wall - dosimetric comparison of common techniques. Int J Radiat Oncol Biol Phys 2002;52:1220-30.
28. Pierce LJ, Glatstein E. Postmastectomy radiotherapy in the management of operable breast cancer. Cancer 1994;74:477-85.
29. Polgar C, Fodor J, Orosz Z, et al. Electron and high-dose-rate brachytherapy boost in the conservative treatment of stage I-II breast cancer. First results of the randomized Budapest boost trial. Strahlenther Onkol 2002;178:615-23.
30. Ragaz J, Jackson SM, Le N, et al. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med 1997;337:956-62.
31. Recht A, Edge SB, Solin LJ, et al. Postmastectomy radiotherapy: guidelines for the American Society of Clinical Oncology. J Clin Oncol 2001;19:1539-69.
32. Recht A, Hayes DF, Eberlein TJ, et al. Local-regional recurrence after mastectomy or breast-conserving therapy. In: Harris JR, Lippmann M, Morrow M, et al., eds. Disease of the breast. Philadelphia: Lippincott, 1996: 649-67.
33. Reitsamer R, Peintinger F, Kopp M, et al. Local recurrence rates in breast cancer patients treated with intraoperative electron-boost radiotherapy versus postoperative external-beam electron-boost irradiation. A sequential intervention study. Strahlenther Onkol 2004;180:38-44.
34. Rutqvist LE, Pettersson D, Johansson H. Adjuvant radiation therapy versus surgery alone in operable breast cancer: long-term follow-up of a randomized clinical trial. Radiother Oncol 1993;26:104-10.
35. Sauer R, Schulz KD, Hellriegel KP. Strahlentherapie nach Mastektomie - Interdisziplinärer Konsensus beendet Kontroverse. Strahlenther Onkol 2001;177:1-9.
36. Schuller P, Bruns F, Hesselmann S, et al. Simulator verification of the accuracy of patient repositioning after virtual simulation. Is physical simulation still needed? Strahlenther Onkol 2002;178:715-21.
37. Stranzl H, Mayer R, Ofner P, et al. Extracapsular extension in positive axillary lymph nodes in female breast cancer patients. Patterns of failure and indications for postoperative locoregional irradiation. Strahlenther Onkol 2004;180:31-7.
38. Strom EA, McNeese MD, Fletcher GH, et al. Results of mastectomy and postoperative irradiation in the management of locoregionally advanced carcinoma of the breast. Int J Radiat Oncol Biol Phys 1991;21:319-23.
39. Uematsu M, Bornstein BA, Recht A, et al. Long-term results of post-operative radiation therapy following mastectomy with or without chemotherapy in stage I-III breast cancer. Int J Radiat Oncol Biol Phys 1993;25:765-70.
40. Valagussa P, Bonadonna G, Veronesi U. Patterns of relapse and survival following radical mastectomy. Analysis of 716 consecutive patients. Cancer 1978;41:1170-8.
41. Whelan TJ, Julian J, Wright J, et al. Does loco-regional radiation therapy improve survival in breast cancer? A meta-analysis. J Clin Oncol 2000;18:1220-9.